Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors.
Fiche publication
Date publication
octobre 2022
Journal
Endocrine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CADIOT Guillaume
Tous les auteurs :
Lelièvre M, Triumbari EKA, Brixi H, Perrier M, Cadiot G, Deguelte S, Morland D
Lien Pubmed
Résumé
Bone metastases (BM) affect 10-30% of patients with small intestine neuroendocrine tumors (siNET), but little descriptive data are available regarding their distribution throughout the skeleton or potential risk factors. Aim of the study is to better describe the imaging characteristics, distribution, and risk factors of siNET bone metastases using 18F-FDOPA PET/CT.
Mots clés
Fluorodopa, Metastasis, Neuroendocrine, PET, Skeleton, Volume
Référence
Endocrine. 2022 10 7;: